Interpace Biosciences, Inc. (IDXG)

OTCMKTS · Delayed Price · Currency is USD

0.8782

+0.0135 (1.56%)

Oct 8, 2025, 1:47 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
Diagnostic Clinical Services	46.93M	Log In	Log In	Log In	Log In	Upgrade
Diagnostic Clinical Services Growth	16.69%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
United States	46.93M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	16.69%	Log In	Log In	Log In	Log In	Upgrade